CAM
TTOO

ClariVest Asset Management’s T2 Biosystems, Inc TTOO Stock Holding History

ClariVest Asset Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-38
Closed -$574K – 795
2018
Q4 		$574K Buy
38
+11
+41% +$258K 0.01% 450
2018
Q3 		$990K Buy
27
+1
+4% +$32.9K 0.02% 425
2018
Q2 		$1.01M Buy
+26
New +$987K 0.02% 441
2015
Q3 		– Sell
-2
Closed -$198K – 662
2015
Q2 		$198K Hold
2
– – 0.01% 410
2015
Q1 		$187K Hold
2
– – 0.01% 407
2014
Q4 		$171K Hold
2
– – 0.01% 363
2014
Q3 		$157K Buy
+2
New +$186K 0.01% 400

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClariVest Asset Management's TTOO Position: Q1 2019 in Review

ClariVest Asset Management sold out of T2 Biosystems, Inc (TTOO) in Q1 2019, closing a stake of 38 shares — an estimated $574K sold.

ClariVest Asset Management first reported a position in TTOO in Q3 2014 and held it in 7 quarters. The position peaked at $1.01M in Q2 2018. 71 funds tracked by Wall St. Rank hold TTOO as of Q1 2019.

  • ClariVest Asset Management reported no remaining T2 Biosystems, Inc position as of Q1 2019 after selling out during the quarter.
  • ClariVest Asset Management sold 38 T2 Biosystems, Inc shares in Q1 2019, an estimated $574K.
  • ClariVest Asset Management first reported a position in T2 Biosystems, Inc in Q3 2014 and held it in 7 quarters.
  • ClariVest Asset Management's T2 Biosystems, Inc position peaked at $1.01M in Q2 2018.
  • 71 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2019.

Based on ClariVest Asset Management's 13F filing for Q1 2019, filed 13 May 2019.